Icon

Icon Central Laboratories launches iSite portal

Tuesday, November 27, 2012 11:17 AM

Dublin-based CRO Icon has launched iSite, a secure web-based portal that drives efficiency by providing investigators 24-hour access to study-specific laboratory information from Icon Central Laboratories.

More... »

Icon launches new FSP strategy

Wednesday, November 7, 2012 10:03 AM

Global CRO Icon has launched a new functional resourcing strategy delivered by a dedicated division, DOCS, consolidating functional service provision (FSP) and resourcing services into one division.

More... »

Icon reports Q3 revenue of $286M

Monday, November 5, 2012 09:24 AM

Icon, a global provider of outsourced development services, reported its financial results for the third quarter ended September 30, 2012. Net revenues for the quarter grew 19% to $286 million compared to $241 million in the same quarter last year.

More... »

Icon launches new medical imaging solution for early trials

Wednesday, October 17, 2012 12:27 PM

Icon,a global provider of outsourced development services, has launched a new medical imaging solution tailored to the unique requirements of early phase trials.

More... »

Icon partners with KoNECT to advance S. Korean clinical trials industry

Wednesday, October 3, 2012 10:43 AM

Icon,a global provider of outsourced development services, and Korea National Enterprise for Clinical Trials (KoNECT) have signed a partnership agreement that aims to advance the clinical trials industry in South Korea.

More... »

ICON adds two to leadership teams in Asia Pacific and Latin America

Friday, September 28, 2012 02:47 PM

ICON,a global provider of outsourced development services, has appointed new members to its Asia Pacific & Latin American teams. New members include Wei Ming Goh as vice president of Asia Pacific and Dennis Hurley as vice president of Latin America.

More... »

Icon expands U.S. and U.K. bioanalytical labs

Monday, September 10, 2012 09:48 AM

Icon,a global provider of outsourced development services, is expanding its U.S. and U.K. bioanalytical facilities to meet the growing demand for biomarker and cell-based assay services.

Icon has increased its bioanalytical laboratories in Whitesboro, N.Y., and Manchester, U.K., by 7,000 and 4,000 square feet, respectively. The expansions allow Icon to house dedicated immunoassay laboratories at each facility for biomarker testing and cell-based assays.

More... »

Icon forms partnership with University College Dublin

Wednesday, September 5, 2012 10:13 AM

Icon,a global provider of outsourced development services, has entered into a strategic partnership with University College Dublin (UCD), Ireland’s largest third-level institution.

More... »

Icon to expand hospital-based presence in translational medicine

Wednesday, August 8, 2012 10:26 AM

Icon, a global provider of outsourced development services, has announced plans to further expand its U.K. hospital-based presence on the Manchester Royal Infirmary Campus.

More... »

Icon appoints three to senior clinical and laboratory positions

Tuesday, July 3, 2012 10:49 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has appointed three additions to the senior management teams of its clinical and central laboratories businesses.

More... »